Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Metformin in Coronary Artery Bypass Graft (CABG) (MetCAB) Trial (MetCAB)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Radboud University
ClinicalTrials.gov Identifier:
NCT01438723
First received: September 21, 2011
Last updated: July 28, 2014
Last verified: November 2011